I am a Professor of Practice and Consultant Histopathologist at the Department of Histopathology, Imperial College London, Hammersmith Campus. My main area of practice and interest is Gynaecologic pathology, and in particular Gynaecological tumour pathology.
My job at Imperial College is a reflection of the ethos of the Academic Health Sciences Centre, where service work, teaching and research work are complimentary.
My research focuses on the identification of diagnostic and prognostic biomarkers and potential therapeutic targets for epithelial tumours, particularly gynaecological tumours. I have special interest in borderline ovarian tumours and sex cord stromal tumours. Recently published work from our laboratory shows that there are molecular subtypes of serous borderline ovarian tumours. Continued work in this area will hopefully lead to the identification of predictive biomarkers for the biological behaviour of individual borderline tumours, as well as the identification of potential therapeutic targets for tumours showing aggressive behaviour; both of which remain to be unmet clinical needs.
et al., 2022, CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study, Cancer, ISSN:0008-543X
et al., 2022, Study protocol for a randomised controlled trial on the use of intra-operative Ultrasound Guided Laparoscopic Ovarian Cystectomy (UGLOC) as a method of fertility preservation in the management of benign ovarian cysts, Bmj Open, Vol:12, ISSN:2044-6055
Uthayanan L, El-Bahrawy M, 2022, Potential roles of claudin-3 and claudin-4 in ovarian cancer management, Journal of the Egyptian National Cancer Institute, Vol:34, ISSN:1110-0362
et al., 2022, Reproductive outcomes in women with Borderline Ovarian Tumours. Does fertility treatment increase the risk of disease recurrence?, 38th Hybrid Annual Meeting of the European-Society-of-Human-Reproduction-and-Embryology (ESHRE), OXFORD UNIV PRESS, Pages:I113-I113, ISSN:0268-1161
Uthayanan L, Wang Z, El-Bahrawy M, 2022, Expression of Claudin 3 and Claudin 4 in Serous Borderline Ovarian Tumours and Low-Grade Serous Ovarian Carcinomas, Virtual 4th Joint Winter Meeting of the Pathological-Society-of-Great-Britain-and-Ireland and the Royal-Society-of-Medicine, WILEY, Pages:S12-S12, ISSN:0022-3417